---
figid: PMC4061885__brainsci-03-01043-g002
figtitle: Main signaling pathways activated by cannabinoid receptors
organisms:
- Oryza sativa
- Diaporthe sclerotioides
- Cannabis sativa
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Ovis aries
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC4061885
filename: brainsci-03-01043-g002.jpg
figlink: /pmc/articles/PMC4061885/figure/brainsci-03-01043-f002/
number: F2
caption: 'Main signaling pathways activated by cannabinoid receptors. The canonical
  signaling pathway initiated by the binding of a cannabinoid to CBRs involves the
  coupling of the receptor to Gi/0 proteins. αi subunits can inhibit the activity
  of adenylyl cyclase (AC) and the synthesis of cAMP. This results in a decreased
  activation of PKA and an increased activation of potassium channels type A, which
  leads to membrane hyperpolarization. α0 subunits can in turn inhibit voltage dependent
  Ca2+ channels contributing to the inhibition of membrane depolarization. βγ subunits
  interact with other intracellular pathways related to PI3K or PKB/Akt. CBRs are
  also coupled to neutral sphingomyelinase (EMN), an enzyme that mediates the generation
  of ceramide from sphingomyelin (EM) in the plasma membrane. Ceramide acts as an
  intracellular signaling molecule than can activate several transcription factors
  including ERK, JNK and p38, and is involved, among other functions, on the control
  of cell fate and survival. AC: adenylyl cyclase; FAN: factor associated with neutral
  sphingomyelinase activation; N, P/Q: voltage-dependent calcium channels type N,
  P/Q; PKA: protein kinase A; PKB/Akt: protein kinase B; ERK: extracellular signal-regulated
  kinase; JNK: c-Jun N-terminal kinase; FAK: focal adhesion kinase; PI3K: phosphoinositide-3
  kinase.'
papertitle: 'Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain
  Injury.'
reftext: David Fernández-López, et al. Brain Sci. 2013 Sep;3(3):1043-1059.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9258998
figid_alias: PMC4061885__F2
figtype: Figure
redirect_from: /figures/PMC4061885__F2
ndex: c7ca31d9-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4061885__brainsci-03-01043-g002.html
  '@type': Dataset
  description: 'Main signaling pathways activated by cannabinoid receptors. The canonical
    signaling pathway initiated by the binding of a cannabinoid to CBRs involves the
    coupling of the receptor to Gi/0 proteins. αi subunits can inhibit the activity
    of adenylyl cyclase (AC) and the synthesis of cAMP. This results in a decreased
    activation of PKA and an increased activation of potassium channels type A, which
    leads to membrane hyperpolarization. α0 subunits can in turn inhibit voltage dependent
    Ca2+ channels contributing to the inhibition of membrane depolarization. βγ subunits
    interact with other intracellular pathways related to PI3K or PKB/Akt. CBRs are
    also coupled to neutral sphingomyelinase (EMN), an enzyme that mediates the generation
    of ceramide from sphingomyelin (EM) in the plasma membrane. Ceramide acts as an
    intracellular signaling molecule than can activate several transcription factors
    including ERK, JNK and p38, and is involved, among other functions, on the control
    of cell fate and survival. AC: adenylyl cyclase; FAN: factor associated with neutral
    sphingomyelinase activation; N, P/Q: voltage-dependent calcium channels type N,
    P/Q; PKA: protein kinase A; PKB/Akt: protein kinase B; ERK: extracellular signal-regulated
    kinase; JNK: c-Jun N-terminal kinase; FAK: focal adhesion kinase; PI3K: phosphoinositide-3
    kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cat2
  - Slc7a2
  - Git2
  - Trpv5
  - Cnr2
  - Cnr1
  - Em
  - Nsmaf
  - ac
  - Ptk2
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Ephb2
  - Mapk1
  - Akt1
  - Akt2
  - Pik3r1
  - SLC7A2
  - GIT2
  - TRPV5
  - CNR2
  - CNR1
  - IQCB1
  - NSMAF
  - CNTRL
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - PTK2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Ephb1
  - Pik3cg
  - psq
  - fan
  - tRNA:Asn-GTT-1-4
  - tRNA:Asn-GTT-1-5
  - tRNA:Asn-GTT-1-1
  - tRNA:Asn-GTT-1-9
  - tRNA:Asn-GTT-1-7
  - tRNA:Asn-GTT-1-6
  - tRNA:Asn-GTT-1-10
  - tRNA:Asn-GTT-1-8
  - tRNA:Asn-GTT-1-3
  - tRNA:Asn-GTT-1-2
  - Go
  - Fak
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - Erk7
  - rl
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
---
